Previous Article | Next Article 
Infect Immun, July 1998, p. 3462-3466, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Bartonella henselae Invasion of Feline
Erythrocytes In Vitro
Jane R.
Mehock,1
Craig E.
Greene,2
Frank C.
Gherardini,1
Tae-Wook
Hahn,1 and
Duncan C.
Krause1,*
Departments of
Microbiology1 and
Small Animal
Medicine,2 University of Georgia, Athens,
Georgia 30602
Received 22 December 1997/Returned for modification 3 February
1998/Accepted 31 March 1998
 |
ABSTRACT |
Bartonella henselae, the causative agent of cat scratch
disease, establishes long-term bacteremia in cats, in which it attaches to and invades feline erythrocytes (RBC). Feline RBC invasion was
assessed in vitro, based on gentamicin selection for intracellular bacteria or by laser confocal microscopy and digital sectioning. Invasion rates ranged from 2 to 20% of the inoculum, corresponding to
infection of less than 1% of the RBC. Invasion was a slow process, requiring >8 h before significant numbers of intracellular bacteria were detected. Pretreatment of the bacteria with trypsin, or of the RBC
with trypsin or neuraminidase, had no effect, but pronase pretreatment
of RBC resulted in a slight increase in invasion frequency. The ability
to model B. henselae invasion of feline RBC in vitro should
permit identification of bacterial surface components involved in this
process and elucidate the significance of RBC invasion to transmission
and infection in cats.
 |
TEXT |
Bartonella henselae
causes cat scratch disease (CSD), bacillary angiomatosis, visceral
peliosis, and endocarditis in humans (1, 5, 14, 22, 23). The
domestic cat is a confirmed reservoir for B. henselae
(15); >90% of CSD cases are associated with cat contact,
typically with superficial trauma in the form of a bite or scratch.
While B. henselae is not readily detectable by PCR in the
saliva or nail clippings of infected cats (8), cat fleas
(Ctenocephalides felis) can harbor B. henselae in
the gut, shed the organism in their feces (12), and transmit
infections to specific-pathogen-free kittens (7). These
findings raise the possibility that B. henselae infections
are acquired by scratching contaminated flea feces into the skin at
sites of flea bites, in much the same way as Bartonella
quintana, the agent of trench fever, is transmitted in the feces
of the human body louse.
The clinical course of experimental B. henselae infection in
cats includes persistent bacteremia accompanied by a specific antibody
response (9, 17). Bacteremic cats are generally asymptomatic
(25) but can experience histopathological lesions in
multiple organs (10). The prevalence of B. henselae bacteremia or Bartonella-specific antibody in
cat populations is striking (4, 6, 11, 13, 18, 24) and may
represent a significant public health threat, particularly for
individuals with frequent cat contact. For example, in a study of 205 feral, clinic, pet, and impounded cats in northern California, 5% were
associated with human cases of CSD or bacillary angiomatosis. However,
40% were positive for blood culture of B. henselae, with
prevalences ranging from 4 to 47% in the pet group, 53% in impounded
cats, and 70% in the feral cat group, and antibodies to B. henselae were detected in 81% of the cats tested (6).
A similar pattern was observed in a study of Australian cat
populations, in which 22 of 77 cats tested (35%) were culture positive
for B. henselae (4); 40% of these were feral and
16% were domestic cats.
Bartonella spp. are believed to require hemin for growth
(20), and they exhibit an affinity for erythrocytes (RBC)
that is best characterized with Bartonella bacilliformis,
the agent of Carrión's disease and verruga peruana
(19). B. bacilliformis is transmitted to humans
by nocturnal sand flies in parts of South America, and upon reaching
the blood it invades and ultimately lyses most circulating RBC, leading
to severe anemia. B. henselae likewise exhibits an affinity
for RBC, although the extent of RBC invasion varies with the host. In
contrast to the bacteremia that is common in cats, blood cultures are
rarely positive for humans, in which the organism appears to localize
primarily in regional lymph nodes (9, 10, 17, 18, 25).
Kordick and Breitschwerdt (16) described the
intraerythrocytic location of B. henselae during persistent
bacteremia in cats. Electron micrographs revealed bacteria within 2.9 to 6.2% of the RBC examined, but no bacteria were found to be free of
RBC or associated with the RBC surface. The significance of RBC
invasion to long-term infections in cats, acquisition by cat fleas, and
transmission to humans is unknown. Detailed investigation of the RBC
invasion process, including the potential isolation of noninvading
mutants, will require a suitable model for RBC invasion in vitro; this was the focus of the present study.
B. henselae invasion of feline RBC was analyzed in vitro as
described for B. bacilliformis invasion of human RBC
(3), with modifications. B. henselae Houston-1
was supplied by R. Regnery (Centers for Disease Control and Prevention,
Atlanta, Ga.) and tested by PCR (21) and indirect
fluorescent antibody binding (9). Bartonella
cultures were grown on plates of heart infusion agar supplemented with
5% defibrinated rabbit blood (HIBA) in 4% CO2 for 6 to 7 days at 35°C. Sterile feline blood, preserved and anticoagulated with
EDTA, was obtained from Harlan Bioproducts (Indianapolis, Ind.).
One-milliliter aliquots were each supplemented with 0.14 ml of
acid-citrate-dextrose anticoagulant solution (Sanofi Animal Health,
Inc., Overland Park, Kans.) to help maintain RBC integrity. Sterility
was confirmed by inoculating HIBA plates and incubating them for up to
7 days at 37°C.
Feline RBC in EDTA and acid-citrate-dextrose were washed three times in
Hanks balanced salt solution without bicarbonate and resuspended at
approximately 1.7 × 108 to 2 × 108/ml, based on direct hemocytometer counts. For each
invasion assay, one HIBA plate containing a lawn of B. henselae cells (6 to 7 days of growth) was overlaid with 1 ml of
Bartonella liquid growth medium (RPMI 1640 without
bicarbonate, supplemented with 1% L-glutamine, HEPES
buffer, sodium pyruvate, nonessential-amino-acid solution, and 2 mg of
hemin/ml [prepared in 0.01 N NaOH]; Sigma Chemical Co., St.
Louis, Mo.) (30). Bacterial cells were suspended in the
liquid growth medium, 2- or 20-µl aliquots were added to
sterile 1.5-ml microcentrifuge tubes, and the total volume in each tube was adjusted to 100 µl with Bartonella liquid growth
medium. A 100-µl aliquot from each HIBA plate was also serially
diluted and plated to determine the viable-cell count (typically
approximately 6.0 × 109 B. henselae
CFU/ml). Feline RBC in Hanks balanced salt solution were added to tubes
containing the B. henselae suspension and incubated at
35°C for various lengths of time, ranging from 1 to 24 h. In
some experiments, the samples were centrifuged at 900 × g for 4 min to increase bacterial association with RBC
(3), but this step did not appear to affect the results.
Feline RBC were separated from unassociated bacteria by washing with
phosphate-buffered saline (PBS), since Percoll gradient centrifugation
(3) resulted in substantial lysis of these RBC.
Evaluation of RBC invasion by confocal microscopy.
Infected RBC were analyzed by laser scanning confocal microscopy to
discriminate between intracellular and epicellular B. henselae cells. RBC invasion samples prepared as described
above were diluted 1:10 or 1:100 in PBS, and 10-µl volumes were added to individual wells of an eight-well glass slide. The slides were air
dried, heat fixed, stained for 20 min with a 1:100 dilution of acridine
orange (0.5 mg/ml), washed in distilled water, and again air
dried. A 1:100 dilution of fluorescein isothiocyanate (1 mg/ml) was
used as a secondary stain for 20 min, after which the slides were
rinsed and air dried. Coverslips were sealed with Citifluor mounting
fluid, and slides were viewed at the University of Georgia Center
for Ultrastructural Research, using a Bio-Rad (Hercules, Calif.) MRC
600 laser scanning confocal microscope with an excitation wavelength of
488 nm and an emission wavelength of 617 nm. Z scans were performed to
section RBC images digitally in depth in increments of 0.5 µm.
Feline RBC are rounded (as opposed to biconcave) and, with a diameter
of 3.9 to 5.5 µm, can be completely traversed in 8 to 11 digital
sections taken in 0.5-µm increments.
Typical results following digital sectioning of infected RBC are shown
in Fig. 1. Figure 1a to d are digital
sections 1, 5, 8, and 11 (from top to bottom, respectively) of feline
RBC following B. henselae invasion in vitro. Bacterial cells
stained with acridine orange were easily distinguished by their
intense fluorescence. The bacterial cell in this series was
weakly fluorescent in the uppermost sections (Fig. 1a and b), but the
fluorescence increased in intensity in section 8 (Fig. 1c).
Significantly, the bacterial cell in Fig. 1c was clearly seen interior
to the edge of the RBC and, based on this observation and the depth of
the section, probably was intracellular. The fluorescence intensity of
the indicated cell diminished as digital sectioning approached the
lower surface of the RBC (Fig. 1d). A similar pattern was observed in
the serial sections shown in Fig. 2. The
images in this series were from sections 2, 6, 8, and 10 (Fig. 2a to d,
respectively) from top to bottom. Likely epicellular bacteria, which
were common in the RBC smears, are evident, suggesting that RBC
association does not lead to rapid invasion. A B. henselae
cell exhibiting a fluorescence pattern similar to that observed in Fig.
1 and consistent with an intracellular location is also evident. Both
bacteria in the upper right corner of Fig. 2a appear to be within the
margin of the RBC. Through optical scanning, however, it was evident
that they were localized in different planes. The bacterial cell
indicated by the arrow in Fig. 2b was barely seen in Fig. 2c and d,
suggesting a location on or near the top of the RBC. In contrast, the
fluorescence pattern of the bacterial cell indicated by the arrowhead
suggested a location in a lower plane that probably corresponds to the
RBC interior. Thus, analysis by confocal microscopy suggests the
presence of both intracellular and epicellular B. henselae
organisms associated with feline RBC but also underscores the
difficulty in distinguishing between each by this technique.

View larger version (99K):
[in this window]
[in a new window]
|
FIG. 1.
Digital sections of feline RBC after infection with
B. henselae, as viewed by laser scanning confocal
microscopy. Shown are sections 1 (a), 5 (b), 8 (c), and 11 (d);
sections were taken in 0.5-µm increments from top to bottom. Note
that the fluorescence intensity of the B. henselae cell
(arrowhead) was low in panels a and b and increased in panel c. The
B. henselae cell can be seen clearly within the RBC membrane
and was probably intracellular. In panel d, the fluorescence intensity
of the Bartonella cell once again diminished. Bar, 5 µm;
magnification, ×1,000.
|
|

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 2.
Digital sections of feline RBC after infection with
B. henselae, as viewed by laser scanning confocal
microscopy. Sections were taken as described for Fig. 1; shown are
sections 2 (a), 6 (b), 8 (c), and 10 (d). The arrowhead indicates a
likely intracellular B. henselae cell, while the arrows
indicate probable epicellular B. henselae cells. Note
that the fluorescence intensity of the organism indicated by the
arrowhead in panel a increased in panel b and then faded in panels c
and d. Bar, 5 µm; magnification, ×1,000.
|
|
Assessment of RBC invasion by gentamicin selection.
Intracellular B. henselae cells were quantitated on the
basis of protection from gentamicin. Invasion mixtures prepared and incubated from 1 to 24 h as described above were treated with gentamicin sulfate (250 µg/ml) for 3 h at 35°C to kill
extracellular B. henselae cells. RBC were centrifuged at
900 × g for 4 min, washed three times in PBS to remove
residual antibiotic, and serially diluted in PBS. Aliquots (0.1 ml)
were each combined with 0.3 ml of sterile water to lyse the RBC, and
100-µl volumes of each dilution were individually inoculated onto
HIBA plates that were subsequently incubated at 35°C in 4%
CO2 for 6 to 7 days. Bartonella viable-cell
counts consistently reflected substantial RBC invasion (Table
1). No CFU were recovered when RBC
infection was carried out at 4°C, reflecting a temperature-dependent
process. Invasion was also dose dependent, but variability in CFU
recovery between experiments was high. CFU counts after gentamicin
selection (reported as percentages of the initial inoculum) ranged from
2 to 17%, averaging 7% for the 24-h incubation. In some experiments,
total CFU before and after the 24-h incubation, prior to the gentamicin treatment, were compared. Little change in viable numbers was observed
during this incubation, consistent with the slow growth of these
bacteria in culture (data not shown). No CFU were recovered when RBC
were omitted, and no spontaneous gentamicin resistance was observed at
the gentamicin concentration used.
Invasion of feline RBC by
B. henselae, based on gentamicin
selection, was a time-dependent process (Table
2). Significant
numbers of intracellular
bacteria were not observed until the
24-h time point postinfection.
This rate was much lower than that
reported for invasion of human RBC
in vitro by
B. bacilliformis (
3), for which
adherence follows a 15- to 30-min lag and invasion
progresses rapidly,
peaking by 6 h (
19). Analysis of infected
RBC by
confocal microscopy suggested that
B. henselae
attachment
to RBC likewise occurred relatively rapidly, with
internalization
being the rate-limiting step. Flagellar function is
thought to
be important in
B. bacilliformis invasion
(
27), but
B. henselae lacks flagella and is
thought to employ a twiddle motility driven
by type IV fimbriae
(
19). This difference in motility may account
for
the lower level of RBC invasion by
B. henselae.
A direct comparison of gentamicin treatment and laser confocal
microscopy for the evaluation of feline RBC invasion by
B. henselae in vitro was made (Table
3). Samples from the same invasion
mixture were processed by the two techniques in parallel.
Bartonella viable-cell counts following gentamicin selection
were comparable
to results obtained previously and totaled between 1 and 10% of
the initial
B. henselae inoculum, corresponding
to invasion of
<1% of the RBC in the invasion mixture. However, by
confocal microscopy,
between 1 and 12% of the feline RBC appeared to
contain intracellular
bacteria. The infection rate determined by
confocal microscopy
is probably less reliable due to the difficulty in
distinguishing
intracellular and epicellular bacteria and the inability
to discriminate
between viable and nonviable bacteria by this
technique. The latter
problem would likely be accentuated by the use of
plate-grown
bacteria for the invasion assay. Furthermore, gentamicin
selection
requires that the bacteria be completely separated from the
extracellular
environment to avoid elimination. Kordick and
Breitschwerdt (
16)
described an apparent pore at the RBC
surface that may reflect
the route of entry into the cell interior. If
these pores persisted
for some time, they might permit accessibility of
the internalized
bacteria to the gentamicin in the extracellular space.
Only when
the pore was sealed would the bacteria be expected to survive
gentamicin selection.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Comparison of gentamicin selection and confocal
microscopy for assessing in vitro feline RBC invasion by
B. henselae
|
|
A preliminary comparison between RBC invasion frequencies in vitro and
in vivo in bacteremic cats was achieved by using gentamicin
selection.
Blood samples from cats experimentally infected with
B. henselae by subcutaneous and intradermal inoculation were
evaluated
for viable-cell counts with and without gentamicin selection.
The infection, sampling, and treatment of cats in experimental
infections were conducted as described previously (
9). Cats
were inoculated intradermally and subcutaneously with 3.5 × 10
4 CFU of a low-passage-number
B. henselae
stock culture grown on
HIBA plates and stored at

70°C prior to use.
For enumeration
of intracellular
B. henselae cells,
gentamicin sulfate was added
to a concentration of 250 µg/ml to whole
blood from a bacteremic
cat and the blood was then incubated for 3 h at 35°C. The blood
was subsequently centrifuged at 900 ×
g for 4 min, and the blood
cell pellet was washed three
times with PBS. RBC were lysed with
sterile distilled water, and the
lysate was serially diluted and
inoculated onto HIBA plates. The total
B. henselae CFU in the
blood was enumerated by lysing the
RBC (without gentamicin treatment)
with sterile distilled water and
then diluting the lysate serially
and inoculating HIBA plates. In a cat
at peak bacteremia, for
example, the total CFU count was 1.8 × 10
5/ml. After gentamicin selection, a value of 2.2 × 10
4 CFU was obtained, representing 12% of the total CFU in
the blood
and within the range of invasion rates observed in vitro.
These
results are very preliminary, and expanded studies are planned
for more-thorough documentation of invasion rates in vivo based
on
gentamicin selection.
Approximately 5% of the RBC examined from cats naturally infected with
B. henselae were reported to contain bacteria, and
no
epicellular bacteria were observed by electron microscopy
(
16).
In the present study, the percentage of RBC containing
intracellular
bacteria on the basis of gentamicin selection was much
lower (

1%)
both in experimentally infected cats (see preceding
paragraph)
and with invasion in vitro. This discrepancy might be due to
any
one of several factors, including differences between natural
and
experimental infections, viable versus total cell counts,
or the
B. henselae strains studied in each case (
2).
Characterization of B. henselae-feline RBC
interaction.
To analyze biochemically the interaction between
B. henselae and feline RBC, we assessed the effects of
protease or neuraminidase pretreatment of the RBC, or protease
pretreatment of the bacteria, on RBC invasion. Treatments were carried
out as described previously for B. bacilliformis
(3), with minor changes. Briefly, trypsin (15, 25, or 50 µg) was added to 1.5-ml microcentrifuge tubes containing feline RBC
or B. henselae cells in Bartonella liquid growth
medium, and the tubes were incubated at 37°C for 10 min. Antitrypsin
was added in a twofold molar excess, and the tubes were placed on ice.
Trypsinized RBC suspensions were evaluated visually for hemolysis, while trypsinized B. henselae cells were diluted and
inoculated on HIBA plates to confirm bacterial viability. In some
experiments, both the bacteria and the RBC were treated with trypsin
(50 µg). Alternatively, RBC were pretreated with type XIV bacterial
protease from Streptomyces griseus (pronase, 1 mg/ml in PBS;
Sigma Chemical Co.) or neuraminidase (C. perfringens
neuraminidase type VIII, 1 U/ml; Sigma Chemical Co.) for 30 min at
37°C. RBC were washed twice with PBS after each treatment and then
used in invasion assays as described above. Trypsin pretreatment of
feline RBC, B. henselae cells, or both had no detectable
effect on invasion, but a 23 to 50% increase in invasion was observed
with pronase-pretreated RBC (data not shown). Pretreatment of
feline RBC with neuraminidase had no effect on invasion, indicating
that sialic acid moieties on the RBC surface are probably not required.
Significantly, the same pattern of resistance to enzymatic pretreatment
of bacteria or RBC was reported for B. bacilliformis
(3, 19, 29), suggesting that similar surface structures may
be functional in the interplay between bacteria and RBC in each case.
Our evaluation of bacteremic cats during natural and experimental
infections suggests the presence of intracellular, epicellular,
and
extracellular bacteria in the blood, with RBC invasion
perhaps
being limited to a small percentage of the bacterial
population.
Significantly, the rate of RBC invasion in vitro
described here
was similarly low. This raises the question of the role
that RBC
invasion may play in the natural history of
B. henselae, and at
least four potential benefits seem likely: (i)
RBC invasion might
confer a nutritional advantage (e.g., hemin
acquisition); (ii)
immune evasion might be enhanced by
intraerythrocytic localization;
(iii) spread to other anatomical sites
(e.g., the liver or spleen)
might be enhanced by RBC invasion; and/or
(iv) survival in the
cat flea, perhaps during the initial stages of
digestion of a
blood meal, may be enhanced for intracellular bacteria.
It is
difficult to reconcile a nutritional advantage with low levels
of
invasion.
B. henselae cells are sensitive to
antibody-independent,
complement-mediated cytolysis (
26);
hence, RBC invasion might
afford a means to escape this defense
mechanism. However, this
fails to account for the high numbers of
extracellular bacteria
seen in experimentally infected cats. There is
insufficient information
regarding the spread of
B. henselae
to major organs in infected
cats to address a possible role for RBC
invasion in this context.
However, Vaughan and Azad (
28)
reported that ingested RBC are
rapidly hemolyzed within human
body lice (
Pediculus humanus) and
cat fleas (
C. felis), vectors for
B. quintana and
B. henselae,
respectively. Intraerythrocytic
B. henselae might withstand initial
digestion
better than their extracellular counterparts and thereby
survive to
replicate in the digestive tract of their arthropod
vector.
 |
ACKNOWLEDGMENTS |
This study was supported by a grant from the University of
Georgia Program in Biological Resources and Biotechnology.
We thank Mark Farmer and Cathy Kelloes from the University of Georgia
Center for Ultrastructural Research for their assistance with confocal
microscopy and Macon Miles, Michelle McDermott, and Erez Sternberg for
their technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, 523 Biological Sciences Building, University of Georgia, Athens, GA 30602. Phone: (706) 542-2671. Fax: (706) 542-2674. E-mail:
DKRAUSE{at}ARCHES.UGA.EDU.
Editor: R. N. Moore
 |
REFERENCES |
| 1.
|
Anderson, B.,
K. Sims,
R. Regnery,
L. Robinson,
M. J. Schmidt,
S. Goral,
C. Hager, and K. Edwards.
1994.
Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR.
J. Clin. Microbiol.
32:942-948[Abstract/Free Full Text].
|
| 2.
|
Batterman, H. J.,
J. A. Peek,
J. S. Loutit,
S. Falkow, and L. S. Tompkins.
1995.
Bartonella henselae and Bartonella quintana adherence to and entry into cultured human epithelial cells.
Infect. Immun.
63:4553-4556[Abstract].
|
| 3.
|
Benson, L. A.,
S. Kar,
G. McLaughlin, and G. M. Ihler.
1986.
Entry of Bartonella bacilliformis into erythrocytes.
Infect. Immun.
54:347-353[Abstract/Free Full Text].
|
| 4.
|
Branley, J.,
C. Wolfson,
P. Waters,
T. Gottlieb, and R. Bradbury.
1996.
Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an Australian cat population.
Pathology
28:262-265[Medline].
|
| 5.
|
Breathnach, A. S.,
J. M. Hoare, and S. J. Eykyn.
1997.
Culture-negative endocarditis: contribution of Bartonella infections.
Heart
77:474-476.
[Abstract/Free Full Text] |
| 6.
|
Chomel, B. B.,
R. C. Abbott,
R. W. Kasten,
K. A. Floyd-Hawkins,
P. H. Kass,
C. A. Glaser,
N. C. Pederson, and J. E. Koehler.
1995.
Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers.
J. Clin. Microbiol.
33:2445-2450[Abstract].
|
| 7.
|
Chomel, B. B.,
R. W. Kasten,
K. Floyd-Hawkins,
B. Chi,
K. Yamamoto,
J. Roberts-Wilson,
A. N. Gurfield,
R. C. Abbott,
N. C. Pederson, and J. E. Koehler.
1996.
Experimental transmission of Bartonella henselae by the cat flea.
J. Clin. Microbiol.
34:1952-1956[Abstract].
|
| 8.
|
Demers, D. M.,
J. W. Bass,
J. M. Vincent,
D. A. Person,
D. K. Noyes,
C. M. Staege,
C. P. Samlaska,
N. H. Lockwood,
R. L. Regnery, and B. E. Anderson.
1995.
Cat-scratch disease in Hawaii: etiology and seroepidemiology.
J. Pediatr.
127:23-26[Medline].
|
| 9.
|
Greene, C. E.,
M. McDermott,
P. H. Jameson,
C. L. Atkins, and A. M. Marks.
1996.
Bartonella henselae infection in cats: evaluation during primary infection, treatment, and rechallenge infection.
J. Clin. Microbiol.
34:1682-1685[Abstract].
|
| 10.
|
Guptill, L.,
L. Slater,
C. C. Wu,
T. L. Lin,
L. T. Glickman,
D. F. Welch, and H. Hogenesch.
1997.
Experimental infection of young specific pathogen-free cats with Bartonella henselae.
J. Infect. Dis.
176:206-216[Medline].
|
| 11.
|
Heller, R.,
M. Artois,
V. Xemar,
D. De Briel,
H. Gehin,
B. Jaulhac,
H. Monteil, and Y. Piemont.
1997.
Prevalence of Bartonella henselae and Bartonella clarridgeiae in stray cats.
J. Clin. Microbiol.
35:1327-1331[Abstract].
|
| 12.
|
Higgins, J. A.,
S. Radulovic,
D. C. Jaworski, and A. F. Azad.
1996.
Acquisition of the cat scratch disease agent Bartonella henselae by cat fleas (Siphonatpera: Pulicidae).
J. Med. Entomol.
33:490-495[Medline].
|
| 13.
|
Jameson, P.,
C. Greene,
R. Regnery,
M. Dryden,
A. Marks,
J. Brown,
J. Cooper,
B. Glaus, and R. Greene.
1995.
Prevalence of Bartonella henselae antibodies in pet cats throughout regions of North America.
J. Infect. Dis.
172:1145-1149[Medline].
|
| 14.
|
Koehler, J. E.
1992.
Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis.
N. Engl. J. Med.
327:1625-1631[Abstract].
|
| 15.
|
Koehler, J. E.,
C. A. Glaser, and J. W. Tappero.
1994.
Rochalimaea henselae infection: a new zoonosis with the domestic cat as reservoir.
JAMA
271:531-535[Abstract/Free Full Text].
|
| 16.
|
Kordick, D. L., and E. B. Breitschwerdt.
1995.
Intraerythrocytic presence of Bartonella henselae.
J. Clin. Microbiol.
33:1655-1656[Abstract].
|
| 17.
|
Kordick, D. L., and E. B. Breitschwerdt.
1997.
Relapsing bacteremia after blood transmission of Bartonella henselae to cats.
Am. J. Vet. Res.
58:492-497[Medline].
|
| 18.
|
Kordick, D. L.,
K. H. Wilson,
D. J. Sexton,
T. L. Hadfield,
H. A. Berkhoff, and E. B. Breitschwerdt.
1995.
Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients.
J. Clin. Microbiol.
33:3245-3251[Abstract].
|
| 19.
|
Minnick, M. F.
1996.
Cell entry and the pathogenesis of Bartonella infections.
Trends Microbiol.
9:343-347.
|
| 20.
|
Myers, W. F.,
L. D. Cutler, and C. L. Wisseman, Jr.
1969.
Role of erythrocytes and serum in the nutrition of Rickettsia quintana.
J. Bacteriol.
97:663-666[Abstract/Free Full Text].
|
| 21.
|
Norman, A. F.,
R. Regnery,
P. Jameson,
C. Greene, and D. C. Krause.
1995.
Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene.
J. Clin. Microbiol.
33:1797-1803[Abstract].
|
| 22.
|
Regnery, R., and J. Tappero.
1995.
Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes.
Emerg. Infect. Dis.
1:16-21.
[Medline] |
| 23.
|
Regnery, R. L.,
B. E. Anderson,
J. E. Clarridge III,
M. C. Rodriguez-Barradas,
D. C. Jones, and J. H. Carr.
1992.
Characterization of a novel Rochalimaea species, R. henselae sp. nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient.
J. Clin. Microbiol.
30:265-274[Abstract/Free Full Text].
|
| 24.
|
Regnery, R. L.,
M. Martin, and J. Olson.
1992.
Naturally occurring Rochalimeae henselae infection in domestic cat.
Lancet
340:557-558[Medline].
|
| 25.
|
Regnery, R. L.,
J. A. Rooney,
A. M. Johnson,
S. L. Nesby,
P. Manzewitsch,
K. Beaver, and J. G. Olson.
1996.
Experimentally induced Bartonella henselae infections followed by challenge exposure and antimicrobial therapy in cats.
Am. J. Vet. Res.
57:1714-1719[Medline].
|
| 26.
|
Rodriguez-Barradas, M. C.,
J. C. Bandres,
R. J. Hamill,
J. Trial,
J. E. Clarridge III,
R. E. Baughn, and R. D. Rossen.
1995.
In vitro evaluation of the role of humoral immunity against Bartonella henselae.
Infect. Immun.
63:2367-2370[Abstract].
|
| 27.
|
Scherer, D. C.,
I. DeBuron-Connors, and M. F. Minnick.
1993.
Characterization of Bartonella bacilliformis flagella and effect of antiflagellin antibodies on invasion of human erythrocytes.
Infect. Immun.
61:4962-4971[Abstract/Free Full Text].
|
| 28.
|
Vaughan, J. A., and A. F. Azad.
1993.
Patterns of erythrocyte digestion by bloodsucking insects: constraints on vector competence.
J. Med. Entomol.
30:214-216[Medline].
|
| 29.
|
Walker, T. S., and H. H. Winkler.
1981.
Bartonella bacilliformis: colonial types and erythrocyte adherence.
Infect. Immun.
31:480-486[Abstract/Free Full Text].
|
| 30.
|
Wong, M. T.,
D. C. Thornton,
R. C. Kennedy, and M. J. Dolan.
1995.
A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens.
J. Clin. Microbiol.
33:742-744[Abstract].
|
Infect Immun, July 1998, p. 3462-3466, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Groebel, K., Hoelzle, K., Wittenbrink, M. M., Ziegler, U., Hoelzle, L. E.
(2009). Mycoplasma suis Invades Porcine Erythrocytes. Infect. Immun.
77: 576-584
[Abstract]
[Full Text]
-
Mandle, T., Einsele, H., Schaller, M., Neumann, D., Vogel, W., Autenrieth, I. B., Kempf, V. A. J.
(2005). Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B henselae. Blood
106: 1215-1222
[Abstract]
[Full Text]
-
Chenoweth, M. R., Greene, C. E., Krause, D. C., Gherardini, F. C.
(2004). Predominant Outer Membrane Antigens of Bartonella henselae. Infect. Immun.
72: 3097-3105
[Abstract]
[Full Text]
-
Rolain, J.-M., Locatelli, C., Chabanne, L., Davoust, B., Raoult, D.
(2004). Prevalence of Bartonella clarridgeiae and Bartonella henselae in Domestic Cats from France and Detection of the Organisms in Erythrocytes by Immunofluorescence. CVI
11: 423-425
[Abstract]
[Full Text]
-
Rolain, J.-M., Maurin, M., Mallet, M.-N., Parzy, D., Raoult, D.
(2003). Culture and Antibiotic Susceptibility of Bartonella quintana in Human Erythrocytes. Antimicrob. Agents Chemother.
47: 614-619
[Abstract]
[Full Text]
-
GREUB, G., RAOULT, D.
(2002). Bartonella: new explanations for old diseases. J Med Microbiol
51: 915-923
[Full Text]
-
Rolain, J. M., La Scola, B., Liang, Z., Davoust, B., Raoult, D.
(2001). Immunofluorescent Detection of Intraerythrocytic Bartonella henselae in Naturally Infected Cats. J. Clin. Microbiol.
39: 2978-2980
[Abstract]
[Full Text]
-
Coleman, S. A., Minnick, M. F.
(2001). Establishing a Direct Role for the Bartonella bacilliformis Invasion-Associated Locus B (IalB) Protein in Human Erythrocyte Parasitism. Infect. Immun.
69: 4373-4381
[Abstract]
[Full Text]
-
O'Reilly, K. L., Parr, K. A., Brown, T. P., Tedder-Ferguson, B., Scholl, D. T.
(2001). Passive Antibody to Bartonella henselae Protects against Clinical Disease following Homologous Challenge but Does Not Prevent Bacteremia in Cats. Infect. Immun.
69: 1880-1882
[Abstract]
[Full Text]
-
Munana, K. R., Vitek, S. M., Hegarty, B. C., Kordick, D. L., Breitschwerdt, E. B.
(2001). Infection of Fetal Feline Brain Cells in Culture with Bartonella henselae. Infect. Immun.
69: 564-569
[Abstract]
[Full Text]
-
Breitschwerdt, E. B., Kordick, D. L.
(2000). Bartonella Infection in Animals: Carriership, Reservoir Potential, Pathogenicity, and Zoonotic Potential for Human Infection. Clin. Microbiol. Rev.
13: 428-438
[Abstract]
[Full Text]
-
O'Reilly, K. L., Bauer, R. W., Freeland, R. L., Foil, L. D., Hughes, K. J., Rohde, K. R., Roy, A. F., Stout, R. W., Triche, P. C.
(1999). Acute Clinical Disease in Cats following Infection with a Pathogenic Strain of Bartonella henselae (LSU16). Infect. Immun.
67: 3066-3072
[Abstract]
[Full Text]
-
Kordick, D. L., Brown, T. T., Shin, K., Breitschwerdt, E. B.
(1999). Clinical and Pathologic Evaluation of Chronic Bartonella henselae or Bartonella clarridgeiae Infection in Cats. J. Clin. Microbiol.
37: 1536-1547
[Abstract]
[Full Text]